Effects of comorbid chronic kidney disease on mortality in idiopathic pulmonary fibrosis patients and influence of pirfenidone

Chronic kidney disease (CKD) is a comorbidity in idiopathic pulmonary fibrosis (IPF), and managing IPF with CKD is challenging due to limited options for antifibrotic therapy. The aim of this study was to examine the prevalence of CKD and prescription status of pirfenidone in IPF patients and to ana...

Descripción completa

Detalles Bibliográficos
Autores principales: Jo, Yong Suk, Kim, Kyung Joo, Rhee, Chin Kook, Kim, Yong Hyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10630477/
https://www.ncbi.nlm.nih.gov/pubmed/37935732
http://dx.doi.org/10.1038/s41598-023-46506-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10630477/
https://www.ncbi.nlm.nih.gov/pubmed/37935732
http://dx.doi.org/10.1038/s41598-023-46506-0

Ejemplares similares